Cardiovascular and antiarrhythmic effects of 1-(4,5-dichloro-2-thienyl)-2-t-butylaminoethanol (QM-5119), a new beta-adrenergic blocking agent.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000526:Alprenolol / Q000494:pharmacology; D000779:Anesthetics, Local / Q000494:pharmacology; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001794:Blood Pressure / Q000187:drug effects; D002082:Butylamines / Q000494:pharmacology; D002415:Cats; D002725:Chloroform / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors; D004562:Electrocardiography; D004837:Epinephrine / Q000037:antagonists & inhibitors; D004983:Ethanolamines / Q000494:pharmacology*; D005260:Female; D006168:Guinea Pigs; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles; D007275:Injections, Intravenous; D008297:Male; D051379:Mice; D010042:Ouabain / Q000037:antagonists & inhibitors; D011433:Propranolol / Q000494:pharmacology; D011930:Reaction Time / Q000187:drug effects; D013623:Tail; D013876:Thiophenes / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D000779:Anesthetics, Local; D002082:Butylamines; D004983:Ethanolamines; D013876:Thiophenes; D010042:Ouabain; D002725:Chloroform; D000526:Alprenolol; D011433:Propranolol; D004837:Epinephrine